Home › Clinical Trials › Cancer Clinical Trial › Myeloid and Monocytic Leukemia › A Randomized (1:1), Double-Blind, Multi-Center, Placebo Controlled Study Evaluating Intensive Chemotherapy With or Without Glasdegib (PF-04449913) or Azacitidine (AZA) With or Without Glasdegib in Patients with Previously Untreated Acute Myeloid Leukemia

Print
A A A

Important information about COVID-19 ›

A Randomized (1:1), Double-Blind, Multi-Center, Placebo Controlled Study Evaluating Intensive Chemotherapy With or Without Glasdegib (PF-04449913) or Azacitidine (AZA) With or Without Glasdegib in Patients with Previously Untreated Acute Myeloid Leukemia

Protocol Number: UCI-17-114

NCT Number: NCT03416179

Condition/Disease: Cancer - Myeloid and Monocytic Leukemia

Principal Investigator: Susan O'Brien

Status: Open

Treatment: Treatment

Drugs: Azacitidine, Cytarabine, Daunorubicin, Glasdegib, Placebo

Phase: III

Age Group: Adult

Scope: National

Learn More:
For information about cancer clinical trials at the UCI Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.